Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography

被引:29
作者
Kaddoumi, A [1 ]
Nakashima, MN [1 ]
Nakashima, K [1 ]
机构
[1] Nagasaki Univ, Grad Sch Pharmaceut Sci, Dept Analyt Res Pharmacoinformat, Nagasaki 852, Japan
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 763卷 / 1-2期
关键词
enantiomer separation; fenfluramine; norfenfluramine; phentermine;
D O I
10.1016/S0378-4347(01)00368-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High-performance liquid chromatography (HPLC) with fluorescence detection has been developed for the simultaneous determination of sympathomimetic amines including ephedrine, norephedrine, 2-phenylethylamine, 4-bromo-2,5-dimethoxyphenylethylamine, phentermine (Phen) and DL-fenfluramine (Fen) in spiked human plasma. Furthermore, an enantioselective HPLC method for the separation Of D-Fen (dexfenfluramine) and L-Fen (levofenfluramine) in addition to their active metabolites D- and L-norfenfluramine (Norf) is described. The detection was achieved at emission wavelength of 430 nm with excitation wavelength of 325 nm for both methods. The analytes were extracted from plasma (100 mul) at pH 10.6 with ethyl acetate using fluoxetine as the internal standard. The extracts were evaporated and derivatized with the fluorescence reagent 4-(4,5-diphenyl-1H-imidazole-2-yl)benzoyl chloride in the presence of carbonate buffer (pH 9.0). A gradient separation was achieved on a C, column for the achiral separation or on a Chiralcel OD-R column for the chiral separation. The methods were fully validated, and shown to have excellent linearity, sensitivity and precision. The chiral method has been applied for the determination Of D- and L-enantiomers of Fen and Norf, in addition to Phen in rat plasma after an intraperitoneal administration of DL-Fen and Phen, simultaneously. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 90
页数:12
相关论文
共 38 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]   METABOLISM AND URINARY EXCRETION IN MAN OF PHENTERMINE AND INFLUENCE OF N-METHYL AND PARA CHLORO-SUBSTITUTION [J].
BECKETT, AH ;
BROOKES, LG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 (04) :288-&
[3]   Determination of phenylisothiocyanate derivatives of amphetamine and its analogues in biological fluids by HPLC-APCI-MS or DAD [J].
Bogusz, MJ ;
Kala, M ;
Maier, RD .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1997, 21 (01) :59-69
[4]  
BRENOT F, 1993, BRIT HEART J, V70, P537
[5]   STUDY OF HUMAN URINARY METABOLISM OF FENFLURAMINE USING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
BROWNSILL, R ;
WALLACE, D ;
TAYLOR, A ;
CAMPBELL, B .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 562 (1-2) :267-277
[6]   GAS-LIQUID-CHROMATOGRAPHIC DETERMINATION OF OPTICAL ISOMERS OF FENFLURAMINE AND NORFENFLURAMINE IN BIOLOGICAL SAMPLES [J].
CACCIA, S ;
JORI, A .
JOURNAL OF CHROMATOGRAPHY, 1977, 144 (01) :127-131
[7]   GAS CHROMATOGRAPHIC MEASUREMENT OF LEVELS OF FENFLURAMINE AND NORFENFLURAMINE IN HUMAN PLASMA, RED CELLS AND URINE FOLLOWING THERAPEUTIC DOSES [J].
CAMPBELL, DB .
JOURNAL OF CHROMATOGRAPHY, 1970, 49 (03) :442-&
[8]  
CAMPBELL DB, 1971, BRIT J PHARMACOL, V43, P465
[9]  
CHEYMOL G, 1995, BRIT J CLIN PHARMACO, V39, P684
[10]   APPLICATION OF QUANTITATIVE GC MASS SPECTROMETRY TO STUDY OF PHARMACOKINETICS OF AMPHETAMINE AND PHENTERMINE [J].
CHO, AK ;
HODSHON, BJ ;
LINDEKE, B ;
MIWA, GT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (09) :1491-1494